Latest News

Survey Reveals Reasons Why Respondents Avoid AATD Trial Participation
Survey Reveals Reasons Why Respondents Avoid AATD Trial Participation

June 19th 2024

A survey found individuals may avoid participating in AATD trials because a trial may require them to go off augmentation therapy.

Robert Gish, MD | Credit: Robert G Gish Consultants, LLC
Robert Gish, MD: Advancements in Therapeutic Development, Combination Therapy in PBC

June 19th 2024

Charlie Strange, MD | Credit: MUSC
Cost, Healthcare Resource Utilization Greater in Patients with AATD with Liver, Lung Disease

June 18th 2024

Kris Kowdley, MD | Credit: Velocity Clinical Research
Positive Interim Analyses of Phase 2b Studies Show Promise for Volixibat in PBC, PSC

June 17th 2024

Jaejun Lee, MD | Credit: ResearchGate
Study Finds Differences in High-Genetic Barrier Nucleos(t)ide Analogue Efficacy for HBV

June 17th 2024

Video Interviews
Podcasts
Autoimmune Hepatitis at ACG 2023, with Gina Choi, MD

More News

© 2024 MJH Life Sciences

All rights reserved.